But they cannot achieve that impact without the means of production at commercial scale and without appropriate forms of financing.” Biomanufacturingīiomanufacturing spans several industries including pharmaceuticals, food and beverage, and chemicals. “In the last five years, the biomanufacturing ecosystem has exploded, and the products poised to come to market are revolutionary.
#Sononym app driver
“Biomanufacturing will be a core driver of 21st-century economic development, akin to how petroleum catalyzed so much of the 20th century’s growth,” Shenderovich, Synonym’s CEO, said in a statement. Synonym says this facility, along with the network of facilities Synonym aims to build, “will tackle the 1000-fold increase in production capacity needed to meet future demand for biomanufactured products,” the company said. facility, a “fermentation farm” that it says can produce large quantities of microbial fermentation products. The funding comes as Synonym announced it’s in pre-development phase of its first U.S. Synonym, founded by Joshua Lachter and Edward Shenderovich, is working to develop an “essential infrastructure” for the biomanufacturing industry-creating a network of facilities where its brand partners can produce their biomanufactured products at commercial scale and standardize manufacturing processes. Synonym, a financing and development platform for biomanufacturing, has raised a pre-seed round of $6.3 million, led by Andreessen Horowitz, Giant Ventures, Blue Horizon, Siddhi Capital, FJ Labs and Global Founders Capital among others.
0 kommentar(er)
